Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RIC group (Research Institute for Chromatography) is a privately held European Contract Research Organization (CRO) specializing in advanced analytical R&D services for the pharmaceutical and biotech industries. They provide high-end analytical support for complex modalities including mAbs, ADCs, peptides, oligonucleotides, cell and gene therapies, and mRNA products. Their services span the entire biopharmaceutical product lifecycle, supporting lead selection, formulation, characterization, comparability studies, and regulatory dossier requirements. They do not have a proprietary drug pipeline but enable drug developers through their expertise and state-of-the-art analytical technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RIC group.